Could AIDS treatments slip through patents loophole?

Paul Smaglik

Nature, 2000, vol. 404, issue 6776, 322-322

Abstract: Washington Shifting perceptions in Washington of the application of patent legislation to genetic information is reflected in the fact a controversial patent issued last month on the gene for a key HIV target protein might not have been approved under recently revised patent guidelines.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35006230 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:404:y:2000:i:6776:d:10.1038_35006230

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35006230

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().